Download Docs
Export

AFRIGEN

90687224 | Trademark

Interested in this case?

Request a Demo Track this case, and find millions of cases like it, let us show you how.
Filed May 3, 2021
Serial No. 90687224
Examining Attorney LINDSEY HEATHER BEN
Class Pharmaceutical and veterinary preparations and substances for the treatment of inflammation, pain, anxiety, restlessness and stress; Pharmaceutical and veterinary preparations and substances that act as an antioxidant, improves sleep and concentration; cosmeceutical preparations and substances, namely, cosmetics, cosmetic skin, body and face creams, lotions and oils; medicinal herbal extracts that act as an anti-inflammatory and antioxidant, relieve pain, improve sleep, improve concentration, relieve anxiety and restlessness, and reduce muscular tension; dietary and nutritional supplements;, namely, magnesium, zinc, folic acid supplements; vitamins and vitamin preparations, namely, vitamin B12, vitamin D1, vitamin D3; topical anesthetics; delivery systems in the nature of topical applications, namely, foams, gels, creams, sprays, lotions and ointments which act as a base and prepare the skin to receive therapeutic preparations that are absorbed into the blood stream through the skin; analgesic preparations; antibiotic preparations; 005; 006; 018; 044; 046; 051; 052
AFRIGEN
Status Notice of Allowance (NOA) sent (issued) to the applicant. Applicant must file a Statement of Use or Extension Request within six months of the NOA issuance date.
Last Updated: 11 months, 4 weeks ago
Filing Date # Docket Text